183
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

How Does Helicobacter pylori Infection Cause Gastric Mucosal Atrophy

, , , , &
Pages 3619-3629 | Published online: 07 Jul 2022

References

  • Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: a systematic review and meta-analysis. PLoS One. 2019;14(7):e0219865. doi:10.1371/journal.pone.0219865
  • Song JH, Kim SG, Jin EH, Lim JH, Yang SY. Risk factors for gastric tumorigenesis in underlying gastric mucosal atrophy. Gut Liver. 2017;11(5):612–619. doi:10.5009/gnl16488
  • Masuyama H, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91(1):30–36. doi:10.1159/000368807
  • Kim HJ, Kim N, Yun CY, Lee HS. The clinical meaning of the “indefinite for atrophy” lesions within gastric mucosa biopsy specimens in a region with a high prevalence of gastric cancer. Helicobacter. 2019;24(5):e12605. doi:10.1111/hel.12605
  • Quach DT, Vilaichone RK, Vu KV, Yamaoka Y, Sugano K, Mahachai V. Helicobacter pylori infection and related gastrointestinal diseases in Southeast Asian Countries: an expert opinion survey. Asian Pac J Cancer Prev. 2018;19(12):3565–3569. doi:10.31557/APJCP.2018.19.12.3565
  • El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney system. Hum Pathol. 1999;30(1):72–77. doi:10.1016/S0046-8177(99)90303-9
  • Udoh MO, Obaseki DE. Histopathological evaluation of H. pylori associated gastric lesions in Benin City, Nigeria. East Afr Med J. 2012;89(12):408–413.
  • Khatoon J, Prasad KN, Prakash Rai R, Ghoshal UC, Krishnani N. Association of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer. Br J Biomed Sci. 2017;74(3):121–126. doi:10.1080/09674845.2017.1278887
  • Wang Y-K, Shen L, Yun T, Yang B-F, Zhu C-Y, Wang S-N. Histopathological classification and follow-up analysis of chronic atrophic gastritis.World. J Clin Cases. 2021;9(16):3838–3847. doi:10.12998/wjcc.v9.i16.3838
  • Wang Y, Shen L, Zhao G, et al. Histomorphological characteristics and pathological types of hyperproliferation of gastric surface epithelial cells. Gastroenterol Res Pract. 2021;2021:8828326. doi:10.1155/2021/8828326
  • Russi S, Calice G, Ruggieri V, et al. Gastric normal adjacent mucosa versus healthy and cancer tissues: distinctive transcriptomic profiles and biological features. Cancers. 2019;11(9):1248. doi:10.3390/cancers11091248
  • Matysiak-Budnik T, Camargo MC, Piazuelo MB, Leja M. Recent guidelines on the management of patients with gastric atrophy: common points and controversies. Dig Dis Sci. 2020;65(7):1899–1903. doi:10.1007/s10620-020-06272-9
  • Souza SM, Valiente AEF, Sá KM, et al. Immunoexpression of LGR4 and beta-catenin in gastric cancer and normal gastric mucosa. Asian Pac J Cancer Prev. 2019;20(2):519–527. doi:10.31557/APJCP.2019.20.2.519
  • Tarnawski AS, Ahluwalia A. Increased susceptibility of aging gastric mucosa to injury and delayed healing: clinical implications. World J Gastroenterol. 2018;24(42):4721–4727. doi:10.3748/wjg.v24.i42.4721
  • Heidari Z, Mahmoudzadeh-Sagheb H, Narouei M. Quantitative changes of gastric mucosa during carcinogenesis using stereological methods. J BUON. 2017;22(4):905–910.
  • Gu H. Role of flagella in the pathogenesis of Helicobacter pylori. Curr Microbiol. 2017;74(7):863–869. doi:10.1007/s00284-017-1256-4
  • Koido S, Odahara S, Mitsunaga M, et al. Diagnosis of Helicobacter pylori infection: comparison with gold standard. Rinsho Byori. 2008;56(11):1007–1013.
  • Sgambato D, Miranda A, Romano L, Romano M. Gut microbiota and gastric disease. Minerva Gastroenterol Dietol. 2017;63(4):345–354. doi:10.23736/S1121-421X.17.02380-7
  • Malfertheiner P, Megraud F, O’Morain CA, et al. European Helicobacter and microbiota study group and consensus panel. Management of Helicobacter pylori infection-The Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. doi:10.1136/gutjnl-2016-312288
  • Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis. 2019;38(1):55–66. doi:10.1007/s10096-018-3414-4
  • Roesler BM, Rabelo-Gonçalves EM, Zeitune JM. Virulence factors of Helicobacter pylori: a review. Clin Med Insights Gastroenterol. 2014;27(7):9–17.
  • Allen LA. Phagocytosis and persistence of Helicobacter pylori. Cell Microbiol. 2007;9(4):817–828. doi:10.1111/j.1462-5822.2007.00906.x
  • Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol. 2019;25(33):4870–4884. doi:10.3748/wjg.v25.i33.4870
  • Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39(1):14–23. doi:10.1016/j.bj.2015.06.002
  • Toyoshima O, Yamaji Y, Yoshida S, et al. Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication. Surg Endosc. 2017;31(5):2140–2148. doi:10.1007/s00464-016-5211-4
  • Kodama M, Murakami K, Okimoto T, et al. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol. 2013;48(11):1249–1256. doi:10.3109/00365521.2013.838994
  • Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113–1124.e5. doi:10.1053/j.gastro.2016.01.028
  • Watari J, Chen N, Amenta PS, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014;20(18):5461–5473. doi:10.3748/wjg.v20.i18.5461